A detailed history of Mendota Financial Group, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Mendota Financial Group, LLC holds 447 shares of JNJ stock, worth $65,194. This represents 0.03% of its overall portfolio holdings.

Number of Shares
447
Previous 442 1.13%
Holding current value
$65,194
Previous $64.6 Million 12.13%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$145.48 - $167.38 $727 - $836
5 Added 1.13%
447 $72.4 Million
Q3 2023

Oct 12, 2023

SELL
$155.75 - $174.48 $39,093 - $43,794
-251 Reduced 36.22%
442 $68.8 Million
Q2 2023

Jul 27, 2023

BUY
$154.35 - $166.11 $61,740 - $66,444
400 Added 136.52%
693 $115 Million
Q1 2023

Apr 24, 2023

SELL
$151.05 - $180.26 $64,045 - $76,430
-424 Reduced 59.14%
293 $51.9 Million
Q4 2022

Feb 03, 2023

BUY
$160.2 - $179.79 $114,863 - $128,909
717 New
717 $127 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mendota Financial Group, LLC Portfolio

Follow Mendota Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendota Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendota Financial Group, LLC with notifications on news.